As of 2026-09-13, the Intrinsic Value of Cullinan Oncology Inc (CGEM) is -16.65 USD. This CGEM valuation is based on the model Peter Lynch Fair Value. With the current market price of 20.59 USD, the upside of Cullinan Oncology Inc is -180.87%.
Based on its market price of 20.59 USD and our intrinsic valuation, Cullinan Oncology Inc (CGEM) is overvalued by 180.87%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -16.65 - -16.65 | -16.65 | -180.87% |
| P/E | (77.93) - (98.91) | (88.92) | -531.9% |
| DDM - Stable | (25.18) - (80.63) | (52.91) | -357.0% |
| DDM - Multi | (18.47) - (47.16) | (26.68) | -229.6% |
| Market Cap (mil) | 1,265.46 |
| Beta | 1.06 |
| Outstanding shares (mil) | 61.46 |
| Enterprise Value (mil) | 1,186.82 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.49% |
| Cost of Debt | 5.00% |
| WACC | 7.70% |